2Clinical and Laboratory Standards Institute.Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically;Approved standard-ninth edition.CLSI document M07-A9[EB/OL].Wayne,PA:CLSI,2012.
3Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing;Twenty-third informational supplement.CLSI document M100-S23[EB/OL].Wayne,PA:CLSI,2013.
4Borer A,Saidel-Odes L,Riesenberg K,et al.Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia[J].Infect Control Hosp Epidemiol,2009,30 (10):972-976.
5Schwaber MJ,Klarfeld-Lidji S,Navon-Venezia S,et al.Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality[J].Antimicrob Agents Chemother,2008,52 (3):1028-1033.
6Yang Q,Wang H,Sun H,et al.Phenotypic and Genotypic Characterization of Enterobacteriaceae with Decreased Susceptibility to Carbapenems:Results from Large Hospital-Based Surveillance Studies in China[J].Antimicrob Agents Chemother,2010,54(1):573-577.
7Sun W,Chen H,Liu Y,et al.Prevalence and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates from 14 Cities in China[J].Antimicrob Agents Chemother,2009,53(9):3642-3649.
8Yahav D,Lador A,Paul M,et al.Efficacy and safety of tigecycline:a systematic review and meta-analysis[J].J Antimicrob Chemother,2011,66 (9):1963-1971.
9Lee YT,Tsao SM,Hsueh PR.Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections[J].Eur J Clin Microbiol Infect Dis,2013,32(9):1211-1220.
10Lin-run Wang, Yang Wang,Yan Lou,et al. The role of quality control circles in sustained improvement of medi- cal quality[J]. Springer Plus, 2013,2 : 141.
